New study reveals the importance of genetic testing for colon cancer patients
on Aug 11th, 2009 | No CommentsPatients who are being treated for metastatic colon cancer should have testing to screen for gene mutations, according to a recent study. Biotechnology company Amgen, Inc. released a statement this month detailing their study into the treatment of metastatic colon cancer with Vectibex, a drug they manufacture. In the study, researchers treated patients who had [...]

